Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
134 Leser
Artikel bewerten:
(0)

Research and Markets - Global Life Science Instruments and Reagents Market - Forecast to 2023 - Key Vendors are Agilent Technologies, BD and Company, Bio-Rad Laboratories, Danaher, Illumina, Merck & Roche Holdings

DUBLIN, Mar 02, 2017 /PRNewswire/ --


Research and Markets has announced the addition of the "Life Science Instruments and Reagents Global Market - Forecast To 2023" report to their offering.

The life science instruments and reagents market is expected to reach $81,325 million by 2023.

Increased focus on R&D expenditure and growth of biotechnology and pharmaceutical industries, technological advancements in analytical devices, growth in funding for research, rising demand of analytical instruments with growing research activities in proteomics, lucrative growth opportunities in emerging markets and increasing demand from various industries. Factors such as high cost of instruments, dearth of skilled professionals and stringent regulations are hampering the market growth.

Geographically, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America dominated the life science instruments and reagents market with the largest share which is driven by factors such as increasing awareness of technology, proximity of companies, and early adoption of latest treatments. The European market is expected to be second largest market, growing at a lower rate mainly due to the stringent regulatory environment and slow growth due to the economic crisis. The Asian market is expected to occupy third place with highest growth due increasing government funding of research, economic prosperity, early adoption of latest technology and the relaxed regulatory environment.

Companies Mentioned:

  • 3M Company
  • AB Sciex
  • Abbott Laboratories, Inc.
  • Abcam
  • Acea Biosciences
  • Admesy
  • Agilent Technologies
  • Airclean Systems
  • Alere Inc.
  • Analytik Jena AG
  • Arctiko
  • Arrayit Corporation
  • Aurora Biomed Inc.
  • Auxilab S.L.
  • BD and Company
  • Beijing Genomics Institute
  • Bio-Rad Laboratories
  • Biocytex
  • Biomerieux SA
  • Biosan
  • 100+ Others

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Overview

4 Spectrometry Global Market

5 Chromatography Global Market

6 Microscopy Global Market

7 PCR Techniques Global Market

8 Flow Cytometry Global Market

9 Laboratory Centrifugation Global Market

10 Electrophoresis Global Market

11 Next Generation Sequencing Global Market

12 Biochips Global Market

13 Automated Liquid Handling and Robotics Global Market

14 Cell Counters Global Market

15 Laboratory Freezers Global Market

16 Others

17 Life Science Instruments and Reagents Global Market, by End Users

18 Life Science Instruments and Reagents, by Region

19 Competitive Landscape

20 Major Companies

For more information about this report visit http://www.researchandmarkets.com/research/tgr87g/life_science

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.